DAX23.877 -0,7%Est505.694 -0,9%MSCI World4.343 -0,1%Top 10 Crypto12,62 -6,3%Nas22.901 +0,1%Bitcoin82.589 +1,5%Euro1,1619 ±0,0%Öl64,39 +2,0%Gold4.080 -2,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Siemens Energy ENER6Y DroneShield A2DMAA Siemens 723610 Allianz 840400 Deutsche Telekom 555750 Tesla A1CX3T Novo Nordisk A3EU6F SAP 716460 Lufthansa 823212 Amazon 906866 RENK RENK73 Alphabet A (ex Google) A14Y6F Infineon 623100
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht tiefer ins Wochenende -- Wall Street schließt uneins -- Kryptowährungen brechen ein -- Siemens Energy, Rheinmetall, Allianz, Novo Nordisk, Highland Critical, DroneShield im Fokus
Top News
Hunderte Euro zu viel gezahlt? 8 Broker im Ordergebühren-Vergleich Hunderte Euro zu viel gezahlt? 8 Broker im Ordergebühren-Vergleich
ETF-Investments: Worauf Anleger beim Factsheet wirklich achten sollten ETF-Investments: Worauf Anleger beim Factsheet wirklich achten sollten
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Cassava Sciences Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
2,39 EUR -0,15 EUR -5,75 %
BMN
2,75 USD -0,18 USD -5,98 %
nachbörslich
BTT
Cassava Sciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.122,26 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PGL8

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS14817C1071

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSAVA

Cassava Sciences Aktien News

DatumMeistgelesen
BenzingaCassava Sciences (SAVA) Stock Is Surging Tuesday: What's Going On?
MotleyFoolCassava Sciences Posts Q2 Loss on Pivot
ZacksDown -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround
Wer­bungCassava Sciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BenzingaCassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
ZacksCassava Sciences (SAVA) Upgraded to Buy: What Does It Mean for the Stock?
PR NewswireShareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA
PR NewswireLost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
PR NewswireSAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireShareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PR NewswireClass Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for Investors - Contact Levi & Korsinsky
PR NewswireShareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
EQS GroupEQS-News: Cassava Sciences, Inc. (SAVA) Investors: February 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireShareholders that lost money on Cassava Sciences, Inc.(SAVA) should contact Levi & Korsinsky about pending Class Action - SAVA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireSAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireFebruary 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SAVA
PR NewswireSAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireLevi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SAVA
ZacksA Post-Mortem on Cassava Sciences
BenzingaUnpacking the Latest Options Trading Trends in Cassava Sciences
ZacksDown -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)
BenzingaCassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today
BenzingaCassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies
BenzingaCassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session
ZacksIs Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireSAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
PR NewswireSAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA

Cassava Sciences News

Cassava Sciences News: auf dieser Seite finden Sie alle Cassava Sciences News und Nachrichten zur Cassava Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Cassava Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Cassava Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.